Physician profile
Jason Patrick Calligas
NPI 1700102449
$4,949.16
in general payments reported to CMS, 2019-2025
21 companies · $1,288 in 2025
The $1,288 reported for 2025 was more than what 84% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $193 · 2020: $173 · 2021: $376 · 2022: $881 · 2023: $943 · 2024: $1,096 · 2025: $1,288.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,326.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,117.36 | 2022-2025 | Inspire |
| Depuy Synthes Sales INC. | $1,022.48 | 2020-2025 | Trumatch, Matrixmidface |
| Medtronic, INC. | $442.04 | 2023-2025 | Nim Vital, Stealthstation S8 Platform, Propel |
| Intersect Ent, INC. | $279.10 | 2019-2021 | |
| Genzyme Corporation | $221.01 | 2024-2025 | |
| Aerin Medical INC. | $179.08 | 2021-2025 | |
| Olympus America INC. | $167.21 | 2020-2024 | Rhino-Laryngo Videoscope, Connecting Tube |
| 3-D Matrix, INC. | $99.44 | 2024 | |
| Glaxosmithkline, LLC. | $72.51 | 2025 | Nucala |
| Tempus Ai, INC | $62.25 | 2024 | Xt Cdx |
| Regeneron Healthcare Solutions, INC. | $45.05 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $33.95 | 2020-2022 | |
| Axogen | $33.43 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.17 | 2019 | |
| Aimmune Therapeutics, INC. | $24.60 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $23.91 | 2024 | |
| Tactile Systems Technology INC | $23.38 | 2022 | |
| Smith+Nephew, INC. | $19.36 | 2022 | |
| Csl Behring | $18.72 | 2022 | |
| Karl Storz Endoscopy-America | $18.63 | 2019 | |
| Kaleo, INC. | $16.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Calligas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.